Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

BACKGROUND: We assessed the sensitivity to adjuvant chemotherapy in cell cycle checkpoint kinase 2 (CHEK2) vs non-CHEK2 breast cancer patients by comparing the contralateral breast cancer incidence and distant disease-free and breast cancer-specific survival between both groups, stratified for adjuv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kriege, M, Hollestelle, A, Jager, A, Huijts, P E A, Berns, E M, Sieuwerts, A M, Meijer-van Gelder, M E, Collée, J M, Devilee, P, Hooning, M J, Martens, J W M, Seynaeve, C
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Epidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4150261/
https://ncbi.nlm.nih.gov/pubmed/24918820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.306
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados